explore -WSS

explore

author：Wikipedia 2025-08-12 08:29:24 - browse：848

Adam's take main illustration — Molly Ferguson/STAT

For two days starting on Sunday, Moonlake Immunotherapeutics happily crunched numbers and shared results from a mid-stage clinical trial that depicted its experimental antibody in the most flattering terms possible.

The drug, called sonelokimab, was “changing the game” for the treatment of a debilitating skin condition called hidradenitis suppurativa, or HS, said Moonlake CEO Jorge Santos da Silva, on a call for investors and analysts. The drug’s benefit for patients placed it “at the top of the heap,” he added.

For other, equally important data from the same study that did not fit Moonlake’s home-run narrative, the company took a DIY approach. Curious about how sonelokimab performed against a treatment that’s already approved for HS? Pull out a calculator and do the math yourself. How badly did a higher dose of the drug underperform a lower dose? Take a guess.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： Tori Bowie and the unacceptable rates of Black maternal death
Next article： Prime Medicine says its gene editing passes test in monkeys

WSS

Medicare eyes cuts to doctors, raises to outpatient clinics in 2024

Gene therapy’s promise and the high cost of hope

Medicare eyes cuts to doctors, raises to outpatient clinics in 2024

Gene therapy’s promise and the high cost of hope

Global childhood vaccinations edge closer to pre

American woman kidnapped in Mexico freed after 8 months in captivity: FBI

Wikipedia

explore

leisure time

United colonoscopy coverage change 'may cost lives,' doctors say

What is microchimerism and how does it affect maternal health?

How to save PrEP access — and even expand it

Sarepta Duchenne therapy fails to meet primary endpoint in trial

Drug repurposing or repositioning? The language matters

Grail faces three suits alleging harassment, retaliation

The high cost of giving birth even with insurance

Travis Kelce and the trap of celebrity vaccine endorsements

Continuity nursing helped my family in our darkest PICU moments

Congress: Eradicate hepatitis C and reduce the deficit

hotspot

Key Senate panel to consider PBM, drug pricing reform package

The health care issue Democrats can’t solve: hospital reform

Travis Kelce and the trap of celebrity vaccine endorsements

American woman kidnapped in Mexico freed after 8 months in captivity: FBI

Who gets to use the title 'doctor'?

After Sarepta trial failure, Duchenne families brace for more debate

focus

hotspot

leisure time

explore